Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases

Journal of Clinical Pathology - Molecular Pathology

Volumn 51, Issue 6, 1998, Pages 333-338

  Rauzy, O ^a   Galoin, S ^a   Chale, J J ^b   Adoue, D ^a   Albarede, J L ^a   Delsol, G ^a   Al Saati, T ^a  

^a CHU PURPAN   (France)

^b CHU Purpan ^*  (France)

Author keywords

Bone marrow; Non lymphoid diseases; Semi nested polymerase chain reaction; T(14; 18) (q32; q21) translocation

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN J CHAIN; PROTEIN BCL 2;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHROMOSOME TRANSLOCATION 14; FEMALE; GENE REARRANGEMENT; HEMATOLOGIC DISEASE; HUMAN; INFANT; LYMPHOCYTE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032411839     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.51.6.333     Document Type: Article

References (26)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994;84:1361-92.
2. Tsujimoto Y, Gorham J, Cossman J, et al. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985;229: 1390-3.
3. Wyatt RT, Ruders RA, Zelenetz A, et al. BCL2 oncogene translocation is mediated by a Z-like consensus. J Exp Med 1992;175:1575-88.
4. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991;349:254-6.
5. Knutsen T. Cytogenetic mechanisms in the pathogenesis and progression of follicular lymphoma. Cancer Surz 1997; 30:163-92.
6. H rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991;6:2274-6.
7. Liu Y, Hernandez AM, Shihata D. et al. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA 1994;91:8910-14.
8. Limpens J, Stad R, Vos C. et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 1995;85:2528-36.
9. H in human blood and organ samples by a quantitative polymerase chain reaction assay. Cancer Res 1995;55:2876-82.
10. H rearrangements in circulating B cells of healthy donors and patients with nonmalignant diseases. J Clin Oncol 1996;14:1333-44.
11. Fuscoe JC, Setzer RW, Collard DD, et al. Quantitation of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogens. Carcinogenesis 1996;17:1013-20.
12. Bell DA, Liu Y, Cortopassi GA. Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J Natl Cancer Inst 1995;87: 223-4.
13. Galoin S, Al Saati T, Schlaifer D, et al. Oligonucleotide clonospecific probe directed against the junctional sequence of t(14;18): a new tool for the assessment of minimal residual disease in follicular lymphomas. Br J Haematol 1996;94:676-84.
14. Berinstein NL, Jamal HH, Kuzniar B, et al. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post-treatment. Leukemia 1993;7: 113-19.
15. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8.
16. Bonner TI, Kerby SB, Sutrave P, et al. Structure and biological activity of human homologs of the raf/mil oncogene. Mol Cell Biol 1985;5:1400-7.
17. Soubeyran P, Cabanillas F, Lee MS. Analysis of the expression of the hybrid gene bcl-2 IgH in follicular lymphomas. Blood 1993;81:122-7.
18. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985;82:7439-43.
19. Lee MS, Chang KS, Cabanillas F, et al. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 1987;237:175-8.
20. Crescenzi M, Seto M, Herzig GP, et al. Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA 1988;85:4869-73.
21. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-7.
22. Ravetch JV, Siebenlist U, Korsmeyer S, et al. Structure of the human immunoglobulin μ locus: characterisation of embryonic and rearranged J and D genes. Cell 1981;27:583-91.
23. Kneba M, Eick S, Hebst H, et al. Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin;s lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing. Cancer Res 1991;51: 3243-50.
24. Gravel S, Delsol G, Al Saati T. Single cell analysis of the t(14;18) (q32;q21) chromosomal translocation in Hodgkin's disease demonstrate the absence of this translocation in neoplastic Hodgkin and Reed-Sternberg cells. Blood 1997;91:2866-74.
25. Gribben JG, Neuberg D, Freedman AS, et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993;81:3449-57.
26. Gribben JG, Schultze JL. The detection of minimal residual disease: implications for bone marrow transplantation. Cancer Treat Res 1997;77:99-120.